Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luigi Pontieri

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Clinical Epidemiology|October 22, 2024
Harmonized Data Quality Indicators Maintain Data Quality in Long-Term Safety Studies Using Multiple Sclerosis Registries/Data Sources: Experience from the CLARION StudyJan Hillert, Helmut Butzkueven, Melinda Magyari, et al.
European Journal of Neurology|October 13, 2021
Ocrelizumab treatment in multiple sclerosis: A Danish population-based cohort studyLuigi Pontieri, Morten Blinkenberg, Stephan Bramow, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 3, 2024
Prognostic factors for disease activity in newly diagnosed teriflunomide-treated patients with multiple sclerosis: a nationwide Danish studyMie Reith Mahler, Melinda Magyari, Luigi Pontieri, et al.
Nature Ecology & Evolution|October 3, 2022
Canalized gene expression during development mediates caste differentiation in antsBitao Qiu, Xueqin Dai, Panyi Li, et al.
European Journal of Neurology|January 28, 2026
A National Danish Effectiveness Study of Ocrelizumab Versus Natalizumab in Multiple SclerosisCamilla Maersk-Moller, Luigi Pontieri, Morten Leif Munding Stilund, et al.
Brain Communications|December 23, 2024
Patterns and predictors of multiple sclerosis phenotype transitionLuigi Pontieri, Nupur Greene, Malthe Faurschou Wandall-Holm, et al.
Therapeutic Advances in Neurological Disorders|September 29, 2023
The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across EuropeRichard Nicholas, Jeff Rodgers, James Witts, et al.
Journal of Neurology|April 1, 2024
Big Multiple Sclerosis Data network: an international registry research networkAnna Glaser, Helmut Butzkueven, Anneke van der Walt, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 23, 2023
Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiersLars Forsberg, Tim Spelman, Pernilla Klyve, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 6, 2024
Disease-modifying treatment and disability progression in subclasses of patients with primary progressive MS: results from the Big MS Data NetworkJohannes Lorscheider, Alessio Signori, Suvitha Subramaniam, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Clinical Epidemiology|October 22, 2024
Harmonized Data Quality Indicators Maintain Data Quality in Long-Term Safety Studies Using Multiple Sclerosis Registries/Data Sources: Experience from the CLARION StudyJan Hillert, Helmut Butzkueven, Melinda Magyari, et al.
European Journal of Neurology|October 13, 2021
Ocrelizumab treatment in multiple sclerosis: A Danish population-based cohort studyLuigi Pontieri, Morten Blinkenberg, Stephan Bramow, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 3, 2024
Prognostic factors for disease activity in newly diagnosed teriflunomide-treated patients with multiple sclerosis: a nationwide Danish studyMie Reith Mahler, Melinda Magyari, Luigi Pontieri, et al.
Nature Ecology & Evolution|October 3, 2022
Canalized gene expression during development mediates caste differentiation in antsBitao Qiu, Xueqin Dai, Panyi Li, et al.
European Journal of Neurology|January 28, 2026
A National Danish Effectiveness Study of Ocrelizumab Versus Natalizumab in Multiple SclerosisCamilla Maersk-Moller, Luigi Pontieri, Morten Leif Munding Stilund, et al.
Brain Communications|December 23, 2024
Patterns and predictors of multiple sclerosis phenotype transitionLuigi Pontieri, Nupur Greene, Malthe Faurschou Wandall-Holm, et al.
Therapeutic Advances in Neurological Disorders|September 29, 2023
The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across EuropeRichard Nicholas, Jeff Rodgers, James Witts, et al.
Journal of Neurology|April 1, 2024
Big Multiple Sclerosis Data network: an international registry research networkAnna Glaser, Helmut Butzkueven, Anneke van der Walt, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 23, 2023
Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiersLars Forsberg, Tim Spelman, Pernilla Klyve, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 6, 2024
Disease-modifying treatment and disability progression in subclasses of patients with primary progressive MS: results from the Big MS Data NetworkJohannes Lorscheider, Alessio Signori, Suvitha Subramaniam, et al.
Pageof 4